These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

548 related items for PubMed ID: 14739713

  • 1. Significance of atrial fibrillation during acute myocardial infarction, and its current management: insights from the GUSTO-3 trial.
    Wong CK, White HD, Wilcox RG, Criger DA, Califf RM, Topol EJ, Ohman EM.
    Card Electrophysiol Rev; 2003 Sep; 7(3):201-7. PubMed ID: 14739713
    [Abstract] [Full Text] [Related]

  • 2. Management and outcome of patients with atrial fibrillation during acute myocardial infarction: the GUSTO-III experience. Global use of strategies to open occluded coronary arteries.
    Wong CK, White HD, Wilcox RG, Criger DA, Califf RM, Topol EJ, Ohman EM, GUSTO-III Investigators.
    Heart; 2002 Oct; 88(4):357-62. PubMed ID: 12231591
    [Abstract] [Full Text] [Related]

  • 3. Rate versus rhythm control and outcomes in patients with atrial fibrillation and chronic kidney disease: data from the GUSTO-III Trial.
    Williams ES, Thompson VP, Chiswell KE, Alexander JH, White HD, Ohman EM, Al-Khatib SM.
    Cardiol J; 2013 Oct; 20(4):439-46. PubMed ID: 23913464
    [Abstract] [Full Text] [Related]

  • 4. Systematic electrocardioversion for atrial fibrillation and role of antiarrhythmic drugs: a substudy of the SAFE-T trial.
    Singh SN, Tang XC, Reda D, Singh BN.
    Heart Rhythm; 2009 Feb; 6(2):152-5. PubMed ID: 19187902
    [Abstract] [Full Text] [Related]

  • 5. Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials.
    Naccarelli GV, Wolbrette DL, Khan M, Bhatta L, Hynes J, Samii S, Luck J.
    Am J Cardiol; 2003 Mar 20; 91(6A):15D-26D. PubMed ID: 12670638
    [Abstract] [Full Text] [Related]

  • 6. Significance of recurrences of new atrial fibrillation in acute myocardial infarction.
    Asanin M, Perunicic J, Mrdovic I, Matic M, Vujisic-Tesic B, Arandjelovic A, Vojvodic A, Marinkovic J, Ostojic M, Vasiljevic Z.
    Int J Cardiol; 2006 May 10; 109(2):235-40. PubMed ID: 16005995
    [Abstract] [Full Text] [Related]

  • 7. Atrial fibrillation: rate control often better than rhythm control.
    Prescrire Int; 2004 Apr 10; 13(70):64-9. PubMed ID: 15148984
    [Abstract] [Full Text] [Related]

  • 8. A prospective, randomized controlled trial comparing the efficacy and safety of sotalol, amiodarone, and digoxin for the reversion of new-onset atrial fibrillation.
    Joseph AP, Ward MR.
    Ann Emerg Med; 2000 Jul 10; 36(1):1-9. PubMed ID: 10874228
    [Abstract] [Full Text] [Related]

  • 9. A randomized trial of prophylactic antiarrhythmic agents (amiodarone and sotalol) in patients with atrial fibrillation for whom direct current cardioversion is planned.
    Vijayalakshmi K, Whittaker VJ, Sutton A, Campbell P, Wright RA, Hall JA, Harcombe AA, Linker NJ, Stewart MJ, Davies A, de Belder MA.
    Am Heart J; 2006 Apr 10; 151(4):863.e1-6. PubMed ID: 16569550
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of sequential antiarrhythmic treatment in sinus rhythm maintenance after successful electrocardioversion in patients with chronic non-valvular atrial fibrillation.
    Kosior D, Opolski G, Torbicki A.
    Med Sci Monit; 2001 Apr 10; 7(1):68-73. PubMed ID: 11208496
    [Abstract] [Full Text] [Related]

  • 11. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: rate and rhythm management.
    Gillis AM, Verma A, Talajic M, Nattel S, Dorian P, CCS Atrial Fibrillation Guidelines Committee.
    Can J Cardiol; 2011 Apr 10; 27(1):47-59. PubMed ID: 21329862
    [Abstract] [Full Text] [Related]

  • 12. A comparison between oral antiarrhythmic drugs in the prevention of atrial fibrillation after cardiac surgery: the pilot study of prevention of postoperative atrial fibrillation (SPPAF), a randomized, placebo-controlled trial.
    Auer J, Weber T, Berent R, Puschmann R, Hartl P, Ng CK, Schwarz C, Lehner E, Strasser U, Lassnig E, Lamm G, Eber B, Study of Prevention of Postoperative Atrial Fibrillation.
    Am Heart J; 2004 Apr 10; 147(4):636-43. PubMed ID: 15077078
    [Abstract] [Full Text] [Related]

  • 13. Clinical correlates of immediate success and outcome at 1-year follow-up of real-world cardioversion of atrial fibrillation: the Euro Heart Survey.
    Pisters R, Nieuwlaat R, Prins MH, Le Heuzey JY, Maggioni AP, Camm AJ, Crijns HJ, Euro Heart Survey Investigators.
    Europace; 2012 May 10; 14(5):666-74. PubMed ID: 22223715
    [Abstract] [Full Text] [Related]

  • 14. External electrical and pharmacological cardioversion for atrial fibrillation, atrial flutter or atrial tachycardias: a network meta-analysis.
    Kukendrarajah K, Ahmad M, Carrington M, Ioannou A, Taylor J, Razvi Y, Papageorgiou N, Mead GE, Nevis IF, D'Ascenzo F, Wilton SB, Lambiase PD, Morillo CA, Kwong JS, Providencia R.
    Cochrane Database Syst Rev; 2024 Jun 03; 6(6):CD013255. PubMed ID: 38828867
    [Abstract] [Full Text] [Related]

  • 15. Atrial fibrillation during acute myocardial infarction: association with all-cause mortality and sudden death after 7-year of follow-up.
    Berton G, Cordiano R, Cucchini F, Cavuto F, Pellegrinet M, Palatini P.
    Int J Clin Pract; 2009 May 03; 63(5):712-21. PubMed ID: 19392921
    [Abstract] [Full Text] [Related]

  • 16. Facilitating electrical cardioversion of persistant atrial fibrillation by antiarrhythmic drugs: update on clinical trial results.
    Sung RJ.
    Card Electrophysiol Rev; 2003 Sep 03; 7(3):300-3. PubMed ID: 14739733
    [Abstract] [Full Text] [Related]

  • 17. Amiodarone and mortality among elderly patients with acute myocardial infarction with atrial fibrillation.
    Kilborn MJ, Rathore SS, Gersh BJ, Oetgen WJ, Solomon AJ.
    Am Heart J; 2002 Dec 03; 144(6):1095-101. PubMed ID: 12486436
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Cardioversion of atrial fibrillation: the use of antiarrhythmic drugs.
    Schilling RJ.
    Heart; 2010 Mar 03; 96(5):333-8. PubMed ID: 19910286
    [Abstract] [Full Text] [Related]

  • 20. Verapamil versus digoxin and acute versus routine serial cardioversion for the improvement of rhythm control for persistent atrial fibrillation.
    Hemels ME, Van Noord T, Crijns HJ, Van Veldhuisen DJ, Veeger NJ, Bosker HA, Wiesfeld AC, Van den Berg MP, Ranchor AV, Van Gelder IC.
    J Am Coll Cardiol; 2006 Sep 05; 48(5):1001-9. PubMed ID: 16949494
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.